We could not find any results for:
Make sure your spelling is correct or try broadening your search.
It has been only a year since Japan's Takeda Pharmaceutical Co. (4502.TO) bought Millennium Pharmaceuticals for $8.8 billion, but now the Cambridge, Mass., biotech is looking to make deals of its...
It has been only a year since Japan's Takeda Pharmaceutical Co. (4502.TO) bought Millennium Pharmaceuticals for $8.8 billion, but now the Cambridge, Mass., biotech is looking to make deals of its...
DALLAS, May 19 /PRNewswire/ -- BeaconEquity.com announces availability of stock alerts on today's news makers. Investors can view all of the daily stock alerts for free by visiting...
OSAKA, Japan, and IRVINE, Calif., May 18 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited (TSE:4502) and IDM Pharma, Inc. (NASDAQ:IDMI) today announced that Takeda America...
IRVINE, Calif., May 11 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (NASDAQ: IDMI) today reported financial results for the quarter ended March 31, 2009. Financial information presented...
IRVINE, Calif., April 13 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (NASDAQ:IDMI), a company focused on the development of innovative cancer products, including MEPACT(R) (mifamurtide), which...
IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (NASDAQ:IDMI), a company focused on the development of innovative cancer products, including MEPACT(R) (known as mifamurtide in...
IRVINE, Calif., March 31 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (NASDAQ:IDMI) today reported financial results for the fourth quarter and full year ended December 31, 2008. Financial...
First New Agent Approved to Treat Osteosarcoma in More Than 20 Years IRVINE, Calif., March 9 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (NASDAQ:IDMI) today announced that the European Commission...
IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (NASDAQ:IDMI) today announced that it is joining the National Organization for Rare Disorders (NORD) and more than 100 patient...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions